To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Dr. Jyoti Patel and Laura O’Brien reflect on available treatment options for patients with stage III non-small cell lung cancer, emphasizing the value of clinical trials.
Patient Laura O’Brien shares the story of her diagnosis of non-small cell lung cancer with expert physician Dr. Jyoti Patel.
Wayne Kuznar
Combining two immunotherapies known as checkpoint inhibitors along with best supportive care prolonged life by two and a half months in patients with advanced colorectal cancer that resisted previous treatments.
Arjun V. Balar, M.D.
An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.
Katie Kosko
An expert describes how far the field has come, with two treatments approved and more in the works.
Jessica Skarzynski
One expert weighs in on the use of new immunotherapy agents and combinations in treating non-small cell lung cancer.
Kristie L. Kahl
An integrative model helped to determine which patients with bladder cancer may benefit from checkpoint inhibitor therapy.
Kristie L. Kahl
The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
Brielle Benyon
Only about 4 percent of adults with cancer are treated on clinical trials, according to one expert. Yet, those results are then applied to everybody.
Jarushka Naidoo, M.B.B.Ch.
Immunotherapy can cause some side effects that patients and practitioners should look out for.

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

Patient Caregiver Advocate Other